FRESENIUS SE+CO.KGAA O.N.
FRESENIUS SE+CO.KGAA O.N./ DE0005785604 /
FRE
|
4/23/2025 10:05:42 AM
|
Chg.
-0.100
|
Volume |
Bid10:05:42 AM |
Ask10:05:42 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
39.630EUR
|
-0.25%
|
-
Turnover: - |
39.630Bid Size: - |
39.650Ask Size: - |
22.29 bill.EUR |
2.53% |
47.12 |
Business description
Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
Management board & Supervisory board
| CEO |
| Michael Sen |
| Management board |
| Sara Hennicken, Pierluigi Antonelli , Robert Möller, Michael Moser |
| Supervisory board |
| Wolfgang Kirsch, Prof. Dr. D. Michael Albrecht, Bernd Behlert , Michael Diekmann , Grit Genster , Frauke Lehmann , Prof. Dr. med. Iris Löw-Friedrich , Susanne Zeidler , Dr. Christoph Zindel , Holger Michel, Harald Steer, Oscar Romero de Paco |
Company data
| Name: |
Fresenius SE & Co. KGaA |
| Address: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
| Phone: |
+49-6172-608-0 |
| Fax: |
- |
| E-mail: |
pr-fre@fresenius.com
|
| Internet: |
www.fresenius.de |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12/31 |
| Free Float: |
56.49% |
| IPO date: |
12/18/1986 |
Investor relations
| Name: |
Markus Georgi |
| IR phone: |
+49-6172-608-2485 |
| IR Fax: |
+49-6172-608-2488 |
| IR e-mail: |
ir-fre@fresenius.com
|
Company calendar
|
CW 19 | 5/7/2025
Interim Report 1st Quarter/3 Months
|
|
CW 21 | 5/23/2025
General Shareholder Meeting
|
|
CW 22 | 5/26/2025
Ex-Dividend
|
|
CW 22 | 5/27/2025
Record Date
|
|
CW 22 | 5/28/2025
Dividend Payment
|
